Ph II of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Treatment of Non-Small Cell Lung Cancer
Clinical trial NCT00850577 · TERMINATED
Trial details
- NCT number
- NCT00850577
- Sponsor
- Bristol-Myers Squibb
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-01
- Primary completion
- 2013-08-01
- Enrollment
- 255
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.